ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,333,361 | -87.1% | 122,821 | -85.4% | 0.01% | -86.8% |
| Q2 2023 | $25,899,680 | -17.5% | 842,540 | -3.2% | 0.05% | -22.1% |
| Q1 2023 | $31,375,429 | -30.6% | 870,814 | -23.9% | 0.07% | -33.3% |
| Q4 2022 | $45,216,452 | +66.0% | 1,144,141 | +68.8% | 0.10% | +50.0% |
| Q3 2022 | $27,239,000 | +560.7% | 677,916 | +590.9% | 0.07% | +580.0% |
| Q2 2022 | $4,123,000 | +15.8% | 98,114 | +7.4% | 0.01% | +42.9% |
| Q1 2022 | $3,560,000 | +75.4% | 91,385 | +79.4% | 0.01% | +75.0% |
| Q4 2021 | $2,030,000 | +1851.9% | 50,945 | +1913.6% | 0.00% | – |
| Q2 2021 | $104,000 | -92.5% | 2,530 | -92.1% | 0.00% | -100.0% |
| Q1 2021 | $1,391,000 | +140.7% | 31,900 | +176.0% | 0.00% | +200.0% |
| Q4 2020 | $578,000 | +725.7% | 11,556 | +589.9% | 0.00% | – |
| Q3 2020 | $70,000 | – | 1,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |